Comparison between drug-eluting bead transarterial chemoembolization versus conventional TACE in elderly patients with colorectal cancer liver metastases: a cohort study - Scorecard - MDSpire
Advertisement
Comparison between drug-eluting bead transarterial chemoembolization versus conventional TACE in elderly patients with colorectal cancer liver metastases: a cohort study
Clinical Scorecard: Evaluation of Drug-Eluting Bead Transarterial Chemoembolization Compared to Conventional TACE in Older Adults with Liver Metastases from Colorectal Cancer: A Cohort Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Revise to accurately reflect the source's emphasis on systemic toxicity.
Target Population
Care Setting
Key Highlights
complete_response_rate
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
E
x
p
a
n
d
t
o
i
n
c
l
u
d
e
s
p
e
c
i
f
i
c
a
d
v
e
r
s
e
e
v
e
n
t
m
o
n
i
t
o
r
i
n
g
p
a
r
a
m
e
t
e
r
s
.
Risks
Patient & Prescribing Data
Elderly patients (≥60 years) with unresectable CRCLM.
DEB-TACE may provide a better PFS without increased AEs compared to cTACE.
